240 related articles for article (PubMed ID: 18162218)
1. The contribution of endothelial activation and injury to end-organ toxicity following allogeneic hematopoietic stem cell transplantation.
Cooke KR; Jannin A; Ho V
Biol Blood Marrow Transplant; 2008 Jan; 14(1 Suppl 1):23-32. PubMed ID: 18162218
[TBL] [Abstract][Full Text] [Related]
2. The release of soluble factors contributing to endothelial activation and damage after hematopoietic stem cell transplantation is not limited to the allogeneic setting and involves several pathogenic mechanisms.
Palomo M; Diaz-Ricart M; Carbo C; Rovira M; Fernandez-Aviles F; Escolar G; Eissner G; Holler E; Carreras E
Biol Blood Marrow Transplant; 2009 May; 15(5):537-46. PubMed ID: 19361745
[TBL] [Abstract][Full Text] [Related]
3. Vascular endothelium as 'novel' target of graft-versus-host disease.
Tichelli A; Gratwohl A
Best Pract Res Clin Haematol; 2008 Jun; 21(2):139-48. PubMed ID: 18503982
[TBL] [Abstract][Full Text] [Related]
4. Vascular endothelium and graft-versus-host disease.
Biedermann BC
Best Pract Res Clin Haematol; 2008 Jun; 21(2):129-38. PubMed ID: 18503981
[TBL] [Abstract][Full Text] [Related]
5. Ocular findings after allogeneic hematopoietic stem cell transplantation.
Tabbara KF; Al-Ghamdi A; Al-Mohareb F; Ayas M; Chaudhri N; Al-Sharif F; Al-Zahrani H; Mohammed SY; Nassar A; Aljurf M
Ophthalmology; 2009 Sep; 116(9):1624-9. PubMed ID: 19729097
[TBL] [Abstract][Full Text] [Related]
6. The lung as a target organ of graft-versus-host disease.
Yanik G; Cooke KR
Semin Hematol; 2006 Jan; 43(1):42-52. PubMed ID: 16412788
[TBL] [Abstract][Full Text] [Related]
7. Thrombotic microangiopathy following allogeneic hematopoietic stem cell transplantation.
Kojouri K; George JN
Curr Opin Oncol; 2007 Mar; 19(2):148-54. PubMed ID: 17272988
[TBL] [Abstract][Full Text] [Related]
8. Advances and challenges in infectious diseases supportive care of patients with hematologic malignancies, hematopoietic stem cell transplantation, and severe aplastic anemia.
Walsh TJ
Semin Hematol; 2009 Jul; 46(3):191-7. PubMed ID: 19549573
[TBL] [Abstract][Full Text] [Related]
9. Counting the cost: markers of endothelial damage in hematopoietic stem cell transplantation.
Woywodt A; Haubitz M; Buchholz S; Hertenstein B
Bone Marrow Transplant; 2004 Dec; 34(12):1015-23. PubMed ID: 15516935
[TBL] [Abstract][Full Text] [Related]
10. In vitro monitoring of endothelial complications following hematopoietic allogeneic stem cell transplantation.
Ganster A; Brucker I; Holler E; Hahn J; Bremm H; Andreesen R; Eissner G
Bone Marrow Transplant; 2004 Feb; 33(3):355-7. PubMed ID: 14676785
[No Abstract] [Full Text] [Related]
11. Translational research efforts in biomarkers and biology of early transplant-related complications.
Paczesny S; Diaz-Ricart M; Carreras E; Cooke KR
Biol Blood Marrow Transplant; 2011 Jan; 17(1 Suppl):S101-8. PubMed ID: 21195297
[TBL] [Abstract][Full Text] [Related]
12. Increased graft content of vascular progenitor cells is associated with reduced toxicity following autologous hematopoietic transplantation.
Iqbal T; Rajagopal T; Halpenny M; Yang L; Martin L; Giulivi A; McDiarmid S; Huebsch L; Allan DS
Exp Hematol; 2008 Apr; 36(4):506-12. PubMed ID: 18261841
[TBL] [Abstract][Full Text] [Related]
13. Clinicopathologic analysis of renal biopsies after haematopoietic stem cell transplantation.
Chan GS; Lam MF; Au WY; Chim S; Tse KC; Lo SH; Fung SH; Lai KN; Chan KW
Nephrology (Carlton); 2008 Jun; 13(4):322-30. PubMed ID: 18221254
[TBL] [Abstract][Full Text] [Related]
14. Acute lung injury after allogeneic stem cell transplantation: from the clinic, to the bench and back again.
Cooke KR
Pediatr Transplant; 2005 Dec; 9 Suppl 7():25-36. PubMed ID: 16305615
[TBL] [Abstract][Full Text] [Related]
15. Hematopoietic stem cell transplantation: a glimpse of the past and a view of the future.
Secola R
J Pediatr Oncol Nurs; 2001; 18(4):171-7. PubMed ID: 11471118
[TBL] [Abstract][Full Text] [Related]
16. The multiple organ dysfunction syndrome in cancer patients undergoing hematopoietic stem cell transplantation.
Haire WD
Semin Thromb Hemost; 1999; 25(2):223-37. PubMed ID: 10357090
[TBL] [Abstract][Full Text] [Related]
17. Thrombotic complications after haematopoietic stem cell transplantation: early and late effects.
Tsakiris DA; Tichelli A
Best Pract Res Clin Haematol; 2009 Mar; 22(1):137-45. PubMed ID: 19285280
[TBL] [Abstract][Full Text] [Related]
18. Bronchiolitis obliterans syndrome (BOS), bronchiolitis obliterans organizing pneumonia (BOOP), and other late-onset noninfectious pulmonary complications following allogeneic hematopoietic stem cell transplantation.
Yoshihara S; Yanik G; Cooke KR; Mineishi S
Biol Blood Marrow Transplant; 2007 Jul; 13(7):749-59. PubMed ID: 17580252
[TBL] [Abstract][Full Text] [Related]
19. The EBMT activity survey 2006 on hematopoietic stem cell transplantation: focus on the use of cord blood products.
Gratwohl A; Baldomero H; Frauendorfer K; Rocha V; Apperley J; Niederwieser D; ;
Bone Marrow Transplant; 2008 Apr; 41(8):687-705. PubMed ID: 18084334
[TBL] [Abstract][Full Text] [Related]
20. Modern management of respiratory failure due to pulmonary mycoses following allogeneic hematopoietic stem-cell transplantation.
Koldehoff M; Zakrzewski JL
Am J Hematol; 2005 Jun; 79(2):158-63. PubMed ID: 15929105
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
